HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations.

Abstract
In six patients with urticaria pigmentosa, population density and ultrastructure of the cutaneous mast cells and histamine levels of the lesional skin were studied before, immediately after, and again 5-8 months after photochemotherapy (PUVA). Immediately after PUVA, the total mast cell number was not reduced, but on separate analysis of the intradermal distribution, significantly fewer mast cells were found in the papillary dermis and correspondingly more mast cells in the adjacent upper dermis. On electron microscopic examination, 4% of the mast cell granules were immature before and 27% after PUVA therapy, based on the lower electron density of the granular matrix. This was associated with a markedly lower histamine content of the lesional skin. Five to eight months after recovery from PUVA, the morphologic changes and the histamine levels had all returned to the pre-PUVA status. These findings were paralleled by a reversal of all clinical beneficial effects that had been observed with PUVA.
AuthorsG Kolde, P J Frosch, B M Czarnetzki
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 83 Issue 3 Pg. 175-8 (Sep 1984) ISSN: 0022-202X [Print] United States
PMID6470520 (Publication Type: Journal Article)
Chemical References
  • Histamine
Topics
  • Cell Count
  • Female
  • Histamine (metabolism)
  • Humans
  • Male
  • Mast Cells (metabolism, pathology, ultrastructure)
  • Middle Aged
  • PUVA Therapy
  • Photochemotherapy
  • Skin (metabolism, pathology, ultrastructure)
  • Time Factors
  • Urticaria Pigmentosa (drug therapy, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: